ZCWPW1 Activators
ZCWPW1 Activators are an array of chemical compounds that indirectly promote the functional activity of ZCWPW1 through mechanisms impacting chromatin dynamics and gene regulation. Forskolin, by stimulating adenylyl cyclase to raise cAMP levels, indirectly potentiates ZCWPW1's role in chromatin modification through PKA-mediated phosphorylation, which could enhance ZCWPW1's ability to interact with histone marks. Additionally, histone deacetylase inhibitors such as Trichostatin A and SAHA increase the acetylation of histones, which may facilitate a chromatin state that is permissive to ZCWPW1's gene regulatory functions. DNA methyltransferase inhibitors like 5-Azacytidine and RG108 reduce DNA methylation levels, which could alter the chromatin landscape in a manner that accentuates ZCWPW1's activity in recognizing specifichistone modifications. The use of Retinoic acid and Epigallocatechin gallate (EGCG) also play roles in modifying gene expression by influencing the chromatin structure, which is likely to increase the efficacy of ZCWPW1 in binding to epigenetic marks.
The functional activity of ZCWPW1 is further affected by the modulation of histone methylation. S-Adenosylmethionine (SAM) boosts the methylation process, which may enhance ZCWPW1's recognition of methylated histones, while the MBD2 peptide inhibitor, by blocking MBD2's interaction with methylated DNA, could indirectly enhance ZCWPW1's function related to gene expression patterns. In addition, compounds like SGC707, BIX-01294, and (-)-JQ1 disrupt the activity of enzymes responsible for histone arginine and lysine methylation or alter the binding of proteins to acetylated histones, respectively. These changes in the methylation and acetylation landscape of chromatin could lead to a more favorable environment for ZCWPW1's interaction with histone marks, thereby increasing its functional activity in the regulation of gene expression without the need for direct activation or increased expression of ZCWPW1 itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased levels of cyclic AMP (cAMP) in cells. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate serine/threonine residues on ZCWPW1, potentially enhancing its chromatin-modifying activities. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which causes an accumulation of acetylated histones. This can create a more relaxed chromatin structure, potentially facilitating ZCWPW1's ability to bind to histone marks and modulate gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, which leads to the hypomethylation of DNA and the alteration of gene expression. ZCWPW1, being associated with histone methylation recognition, could have enhanced function due to changes in chromatin structure. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences gene expression by activating retinoic acid receptors, which can lead to chromatin remodeling. As ZCWPW1 is involved in reading histone modifications, this remodeling could enhance ZCWPW1's activity in gene regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit DNA methyltransferases, potentially leading to DNA hypomethylation. This could facilitate ZCWPW1's access to chromatin and enhance its role in gene regulation through histone modification recognition. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is another histone deacetylase inhibitor, leading to increased acetylation of histones. This can promote a chromatin environment that is conducive to ZCWPW1's function in gene regulation through modification recognition. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
SAM serves as a methyl donor in various methylation reactions catalyzed by DNA and histone methyltransferases. Enhanced methylation can influence ZCWPW1's interaction with chromatin by modifying the recognition of methylated histone marks. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor that prevents DNA methylation. This could potentially increase ZCWPW1's ability to bind methylated histones due to changes in the chromatin landscape. | ||||||
SGC707 | 1687736-54-4 | sc-507461 | 1 mg | $48.00 | ||
SGC707 is an allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3). By inhibiting PRMT3, there may be changes in histone arginine methylation, potentially affecting ZCWPW1's recognition and binding to these marks. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
BIX-01294 is a G9a histone methyltransferase inhibitor, leading to reduced methylation of H3K9. ZCWPW1 could be influenced by the subsequent changes in chromatin structure and histone mark availability. | ||||||